<p>A comprehensive understanding of the emergence of therapy resistance in cancer requires new approaches capable of generating and characterizing drug resistant cell lines at scale. Here, we present the EVolution Of Lineages in Vitro (EVOLV) platform, a high-throughput approach for generating diverse libraries of viable, drug-resistant cell lines from a common progenitor. EVOLV enables deeper insights into the genomics of drug resistance as well as into the complex interplay among genomic, transcriptomic, and functional layers during cancer evolution.</p>

Uncovering Principles of Adaptive Regulation in Cancer Resistance Through    Deep Evolutionary Profiling

Drug Resistance study with RNA-Seq, SNV (.MAF) + 1 more data on dbGaP (2 participants)